Barry Levenfeld is one of Israel’s leading lawyers, representing Israeli and international corporate clients for over 35 years. Having joined the firm in 1988, he became a partner in 1992. He has represented many leading multinational technology and other Israeli and overseas companies with respect to M&A transactions, and acted for prominent Israeli and foreign private equity and venture capital funds on fund formation and portfolio investments. He also handles complex intellectual property transactions, including strategic partnering and licensing, in the life sciences, software, semiconductor and other technology fields. In addition, he represents issuers and underwriters in initial public offerings and other securities transactions in Israel, the United States and other countries.

Barry graduated magna cum laude from Harvard College in 1976, and from Harvard Law School in 1980. He holds a Senior Lecturer position at the Hebrew University Law Faculty, teaching high-tech corporate finance, and is the author of many professional articles related to M&A, computer contracting, venture capital and life sciences. He also speaks on these issues at conferences and seminars.

Barry is a member of the New York Bar (1981) and the Israeli Bar Association (1985).

He is also a member of the Board of Directors of the Alyn Hospital Pediatric & Adolescent Rehabilitation Center in Jerusalem. He is an avid cyclist and has actively organized and participated in Israel’s largest charity bicycle ride for Alyn. Barry is the Chairman of the Board of Adam, Teva v’Din, Israel’s leading environmental advocacy group, and a member of the Board of the Immigrant Hotline, an organization that advocates for the rights of refugees.

Barry is fluent in English and Hebrew.



  • Represented Nvidia Corporation in the acquisition of Mellanox Technologies for over $6 billion.
  • Represented Palo Alto Networks in the acquisition of Cider Security for $300 million, Talon Cyber Security for a reported $650 million and Dig Security for a reported $350 million.
  • Represented National Instruments in the acquisition of OptimalPlus for $365 million.
  • Represented Becton-Dickinson in a number of acquisitions of Israeli companies.
  • Represented IBM in the acquisition of and various other companies.
  • Represented EssilorLuxottica in the acquisition of 50% of Shamir Optical for over $500 million, and of Nuance Hearing for an undisclosed amout.
  • Represented Boston Scientific in the acquisition of the laser surgery division of Lumenis for over $1 billion.
  • Represented PayPal, eBay, Stryker, Snap and Mastercharge in the acquisition of Israeli companies.


Healthcare and Life Sciences, Commercial, Corporate and M&A ,Hi-Tech and Startups
Global 2024: Corporate/M&A
Thought Leader 2024: M&A and Governance Capital Markets Life Sciences Global Leader 2023: Capital Markets - Debt & Equity Corporate Governance Life Sciences - Transactional M&A M&A and Governance
Investment funds, M&A and Private equity
Top Ranked in the field of Corporate/M&A
Top Ranked in the fields of M&A, Healthcare and Life Sciences

Chambers Global

‘Barry Levenfeld is an eminent lawyer who acts on major, high-value M&A and has a particular presence on cross-border mandates involving US companies, with a focus on the technology sector.’

1980 Harvard Law School | J.D.
1976 Harvard College | B.A.
1985 Israel
1981 New York
Barry Levenfeld

Barry Levenfeld

31 Hillel Street, Jerusalem
Barry Levenfeld